Polymorphisms spanning the 0N exon and promoter of the estrogen receptor-beta (ERβ) gene ESR2 are associated with venous ulceration

Clinical Genetics

Volumn 73, Issue 1, 2008, Pages 55-61

  Ashworth, J J ^a   Smyth, J V ^b   Pendleton, N ^a   Horan, M ^a   Payton, A ^a   Worthington, J ^a   Ollier, W E ^a   Ashcroft, Gillian ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Haplotype; Inflammation; Skin; Steroid hormone; Wound

Indexed keywords

ESTROGEN RECEPTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA TRANSCRIPTION; EXON; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCER; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR BETA; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; TUMOR NECROSIS FACTOR-ALPHA; VARICOSE ULCER;

EID: 37249030347     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00927.x     Document Type: Article

References (29)

1. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: Extent of the problem and provision of care. Br Med J (Clin Res Ed) 1985: 290: 1855-1856.
2. Callam MJ, Harpur DR, Dale JJ, Ruckley CV. Chronic ulcer of the leg: clinical history. Br Med J (Clin Res Ed) 1987: 294: 1389-1391.
3. Coleridge-Smith PD. Deleterious effects of white cells in the course of skin damage in CVI. Int Angiol 2002: 2: 26-32.
4. Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002: 359: 675-677.
5. Berard A, Kahn SR, Abenhaim L. Is hormone replacement therapy protective for venous ulcer of the lower limbs? Pharmacoepidemiol Drug Saf 2001: 10: 245-251.
6. Ashcroft GS, Dodsworth J, van Boxtel E et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997: 3: 1209-1215.
7. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999: 155: 1137-1146.
8. Enmark E, Gustafsson JA. Estrogen receptors - an overview. J Intern Med 1999: 246: 133-138.
9. Kos M, Reid G, Denger S, Gannon F. Minireview: Genomic organisation of the human ERα gene promoter region. Mol Endocrinol 2001: 15: 2057-2063.
10. Shoda T, Hirata S, Kato J, Hoshi K. Cloning of the novel isoform of the estrogen receptor beta cDNA (ERβ isoform M cDNA) from the human testicular cDNA library. J Steroid Biochem Mol Biol 2002: 82: 201-208.
11. Siomi H, Dreyfuss G. RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 1997: 7: 345-353.
12. Leff SE, Rosenfeld MG, Evans RM. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem 1986: 55: 1091-1117.
13. Johnson PF, McKnight SL. Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem 1989: 58: 799-839.
14. Ashworth JJ, Smyth JV, Pendleton N et al. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J Steroid Biochem Mol Biol 2005: 97: 266-270.
15. Makridakis NM, Reichardt JK. Multiplex automated primer extension analysis: Simultaneous genotyping of several polymorphisms. Biotechniques 2001: 31: 1374-1380.
16. Ben-Avi L, Durst R, Shpitzen S, Leitersdorf E, Meiner V. Apolipoprotein E genotyping: Accurate simple high throughput method using ABI Prism SNaPshot Multiplex System. J Alzheimers Dis 2004: 6: 497-501.
17. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000: 8: 13-25.
18. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000: 50: 133-139.
19. Labrie F. Intracrinology. Mol Cell Endocrinol 1991: 78: 113-118.
20. Labrie F, Belanger A, Luu-The V et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging. Steroids 1998: 63: 322-328.
21. Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M. Intracrinology and the skin. Horm Res 2000: 54: 218-229.
22. Hirata S, Shoda T, Kato J, Hoshi K. The multiple untranslated first exons system of the human estrogen receptor beta (ERβ) gene. J Steroid Biochem Mol Biol 2001: 78: 33-40.
23. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001: 276: 17808-17814.
24. Shim GJ, Wang L, Andersson S et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci U S A 2003: 100: 6694-6699.
25. Follettie MT, Pinard M, Keith JC Jr et al. Organ mRNA and plasma proteome changes in the adjuvant-induced arthritis model: Responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology 2006: 147: 714-723.
26. Baker AE, Brautigam VM, Watters JJ. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004: 145: 5021-5032.
27. Carswell HV, Macrae IM, Gallagher L, Harrop E, Horsburgh KJ. Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 2004: 287: 1501-1504.
28. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/ reperfusion injury. J Mol Cell Cardiol 2005: 38: 289-297.
29. An J, Ribeiro RC, Webb P et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A 1999: 96: 15161-15166.